Exosomes induce and reverse monocrotaline-induced pulmonary hypertension in mice

Cardiovascular Research

Volumn 110, Issue 3, 2016, Pages 319-330

  Aliotta, Jason M ^a   Pereira, Mandy ^a   Wen, Sicheng ^a   Dooner, Mark S ^a   Del Tatto, Michael ^a   Papa, Elaine ^a   Goldberg, Laura R ^a   Baird, Grayson L ^b   Ventetuolo, Corey E ^a   Quesenberry, Peter J ^a   Klinger, James R ^a  

^a BROWN UNIVERSITY   (United States)

^b RHODE ISLAND HOSPITAL   (United States)

Author keywords

Exosomes; Extracellular vesicles; Mesenchymal stem cells; MicroRNA; Pulmonary hypertension

Indexed keywords

MICRORNA; MICRORNA 122; MICRORNA 124; MICRORNA 127; MICRORNA 145; MICRORNA 19B; MICRORNA 20A; MICRORNA 20B; MICRORNA 34A; MONOCROTALINE; SMALL UNTRANSLATED RNA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL FRACTIONATION; CELL ISOLATION; CELL POPULATION; CELL PROLIFERATION; CONTROLLED STUDY; EXOSOME; HEART LEFT VENTRICLE; HEART RIGHT VENTRICLE; HEART SEPTUM; INJECTION; LUNG; LUNG VASCULAR RESISTANCE; MALE; MEMBRANE MICROPARTICLE; MESENCHYMAL STEM CELL; MONOCROTALINE-INDUCED PULMONARY HYPERTENSION; MOUSE; NONHUMAN; PLASMA; PRIORITY JOURNAL; PULMONARY HYPERTENSION; ANIMAL; C57BL MOUSE; CASE CONTROL STUDY; CELL CULTURE; CHEMICALLY INDUCED; COMPARATIVE STUDY; DISEASE MODEL; GENE EXPRESSION REGULATION; GENETICS; HUMAN; HYPERTENSION, PULMONARY; HYPERTROPHY, RIGHT VENTRICULAR; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMA CELL; METABOLISM; PATHOPHYSIOLOGY; PULMONARY ARTERY; TRANSPLANTATION; VASCULAR REMODELING;

ANIMALS; CASE-CONTROL STUDIES; CELL-DERIVED MICROPARTICLES; CELLS, CULTURED; DISEASE MODELS, ANIMAL; EXOSOMES; FAMILIAL PRIMARY PULMONARY HYPERTENSION; GENE EXPRESSION REGULATION; HUMANS; HYPERTENSION, PULMONARY; HYPERTROPHY, RIGHT VENTRICULAR; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MICE, INBRED C57BL; MICRORNAS; MONOCROTALINE; PULMONARY ARTERY; VASCULAR REMODELING;

EID: 84973311486     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvw054     Document Type: Article

References (45)

1. Rabinovitch M, Guignabert C, Humbert M, Nicolls MR. Inflammation and immunity in the pathogenesis of pulmonary arterial hypertension. Circ Res 2014;115:165-175.
2. Mathew R. Pathogenesis of pulmonary hypertension: a case for caveolin-1 and cell membrane integrity. Am J Physiol Heart Circ Physiol 2014;306:H15-H25.
3. Bienertova-Vasku J, Novak J, Vasku A. MicroRNAs in pulmonary arterial hypertension: pathogenesis, diagnosis and treatment. J Am Soc Hypertens 2015;9:221-234.
4. Guignabert C, Tu L, Girerd B, Ricard N, Huertas A, Montani D, Humbert M. New molecular targets of pulmonary vascular remodeling in pulmonary arterial hypertension: importance of endothelial communication. Chest 2015;147:529-537.
5. Grant JS, White K, MacLean MR, Baker AH. MicroRNAs in pulmonary arterial remodeling. Cell Mol Life Sci 2013;70:4479-4494.
6. Arroyo JD, Chevillet JR, Kroh EM, Ruf IK, Pritchard CC, Gibson DF et al. Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc Natl Acad Sci USA 2011;108:5003-5008.
7. Ratajczak J, Wysoczynski M, Hayek F, Janowska-Wieczorek A, Ratajczak MZ. Membrane-derived microvesicles: important and underappreciated mediators of cell-to-cell communication. Leukemia 2006;20:1487-1495.
8. Théry C, Ostrowski M, Segura E. Membrane vesicles as conveyors of immune responses. Nature Rev Immunol 2009;9:581-593.
9. Deregibus MC, Cantaluppi V, Calogero R, Lo Iacono M, Tetta C, Biancone L. Endothelial progenitor cell derived microvesicles activate an angiogenic program in endothelial cells by a horizontal transfer of mRNA. Blood 2007;110:2440-2448.
10. Baj-Krzyworzeka M, Szatanek R, Weglarczyk K, Baran J, Urbanowicz B, Branski P. Tumor-derived microvesicles carry several surface determinants and mRNA of tumor cells and transfer some of these determinants to monocytes. Cancer Immunol Imunother 2006;55:808-818.
11. Rozmyslowicz T, Majka M, Kijowski J, Murphy SL, Conover DO, Poncz M. Platelet-and megakaryocyte-derived microparticles transfer CXCR4 receptor to CXCR4-null cells and make them susceptible to infection by X4-HIV. AIDS 2003;17:33-42.
12. Aliotta JM, Sanchez-Guijo FM, Dooner GJ, Johnson KW, Dooner MS, Greer KA et al. Alteration of marrow cell gene expression, protein production, and engraftment into lung by lung-derived microvesicles: a novel mechanism for phenotype modulation. Stem Cells 2007;25:2245-2256.
13. Aliotta JM, Pereira M, Johnson KW, de Paz N, Dooner MS, Puente N et al. Microvesicle entry into marrow cells mediates tissue-specific changes in mRNA by direct delivery of mRNA and induction of transcription. Exp Hematol 2010;38:233-245.
14. Aliotta JM, Pereira M, Amaral A, Sorokina A, Igbinoba Z, Hasslinger A et al. Induction of pulmonary hypertensive changes by extracellular vesicles from monocrotaline-treated mice. Cardiovasc Res 2013;100:354-362.
15. Lee C, Mitsialis SA, Aslam M, Vitali SH, Vergadi E, Konstantinou G et al. Exosomes mediate the cytoprotective action of mesenchymal stromal cells on hypoxia-induced pulmonary hypertension. Circulation 2012;126:2601-2611.
16. Zhu H, Guo ZK, Jiang XX, Li H, Wang XY, Yao HY et al. A protocol for isolation and culture of mesenchymal stem cells from mouse compact bone. Nat Protoc 2010;5: 550-560.
17. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(2delta delta C(T)) method. Methods 2001;25:402-408.
18. Amabile N, Guignabert C, Montani D, Yeghiazarians Y, Boulanger CM, Humbert M. Cellular microparticles in the pathogenesis of pulmonary hypertension. Eur Respir J 2013;42:272-279.
19. Hale AE, White K, Chan SY. Hypoxamirs in pulmonary hypertension: breathing new life into pulmonary vascular research. Cardiovasc Diagn Ther 2012;2:200-202.
20. Mendell JT. miRiad roles for the miR-17-92 cluster in development and disease. Cell 2008;133:217-222.
21. Brock M, Trenkmann M, Gay RE, Michel BA, Gay S, Fischler M et al. Interleukin-6 modulates the expression of the bone morphogenic protein receptor type II through a novel STAT3-microRNA cluster 17/92 pathway. Circ Res 2009;104:1184-1191.
22. Machado R, Aldred M, James V, Harrison R, Patel B, Schwalbe E et al. Mutations of the TGF-beta type II receptor BMPR2 in pulmonary arterial hypertension. Human Mut 2006;27:121-132.
23. Thomson J, Machado R, Pauciulo M, Morgan N, Humbert M, Elliott G et al. Sporadic primary pulmonary hypertension is associated with germline mutations of the gene encoding BMPR-II, a receptor member of the TGF-beta family. J Med Gen 2000;37: 741-745.
24. Brock M, Samillan VJ, Trenkmann M, Schwarzwald C, Ulrich S, Gay RE et al. AntagomiR directed against miR-20a restores functional BMPR2 signalling and prevents vascular remodelling in hypoxia-induced pulmonary hypertension. Eur Heart J 2014;35: 3203-3211.
25. White K, Loscalzo J, Chan SY. Holding our breath: the emerging and anticipated roles of microRNA in pulmonary hypertension. Pulm Circ 2012;2:278-290.
26. Yang S, Banerjee S, Freitas Ad, Cui H, Xie N, Abraham E et al. miR-21 regulates chronic hypoxia-induced pulmonary vascular remodeling. Am J Physiol Lung Cell Mol Physiol 2012; 302:L521-L529.
27. Ji R, Cheng Y, Yue J, Yang J, Liu X, Chen H et al. MicroRNA expression signature and antisense-mediated depletion reveal an essential role of MicroRNA in vascular neointimal lesion formation. Circ Res 2007;100:1579-1588.
28. Parikh VN, Jin RC, Rabello S, Gulbahce N, White K, Hale A et al. MicroRNA-21 integrates pathogenic signaling to control pulmonary hypertension: results of a network bioinformatics approach. Circulation 2012;125:1520-1532.
29. Davis-Dusenbery BN, Chan MC, Reno KE, Weisman AS, Layne MD, Lagna G et al. Down-regulation of Kruppel-like factor-4 (KLF4) by microRNA-143/145 is critical for modulation of vascular smooth muscle cell phenotype by transforming growth factor-beta and bone morphogenetic protein 4. J Biol Chem 2011;286: 28097-28110.
30. Caruso P, Dempsie Y, Stevens HC, McDonald RA, Long L, Lu R et al. A role for miR-145 in pulmonary arterial hypertension: evidence from mouse models and patient samples. Circ Res 2012;111:290-300.
31. Lai M, Du G, Shi R, Yao J, Yang G,Wei Y et al. MiR-34a inhibits migration and invasion by regulating the SIRT1/p53 pathway in human SW480 cells. Mol Med Rep 2015;11: 3301-3307.
32. Gupta P, Cairns MJ, Saksena NK. Regulation of gene expression by microRNA in HCV infection and HCV-mediated hepatocellular carcinoma. Virol J 2014;11:64.
33. Xie T, Liang J, Liu N,Wang Q, Li Y, Noble PWet al. MicroRNA-127 inhibits lung inflammation by targeting IgG Fcg receptor I. J Immunol 2012;188:2437-2444.
34. Ma N, Chen F, Shen SL, ChenW, Chen LZ, Su Q et al. MicroRNA-129-5p inhibits hepatocellular carcinoma cell metastasis and invasion via targeting ETS1. Biochem Biophys Res Commun 2015;461:618-623.
35. Ge T, Yin M, Yang M, Liu T, Lou G. MicroRNA-302b suppresses human epithelial ovarian cancer cell growth by targeting RUNX1. Cell Physiol Biochem 2014;34:2209-2220.
36. Chen L, Li ZY, Xu SY, Zhang XJ, Zhang Y, Luo K et al. Upregulation of miR-107 inhibits glioma angiogenesis and VEGF expression. Cell Mol Neurobiol 2016;36:113-120.
37. Sun Y, Zhao X, Luo M, Zhou Y, RenW, Wu K et al. The pro-apoptotic role of the regulatory feedback loop between miR-124 and PKM1/HNF4a in colorectal cancer cells. Int J Mol Sci 2014;15:4318-4332.
38. Adlakha YK, Saini N. miR-128 exerts pro-apoptotic effect in a p53 transcriptiondependent and-independent manner via PUMA-Bak axis. Cell Death Dis 2013;4: e542.
39. Wang J, Yang B, Han L, Li X, Tao H, Zhang S et al. Demethylation of miR-9-3 and miR-193a genes suppresses proliferation and promotes apoptosis in non-small cell lung cancer cell lines. Cell Physiol Biochem 2013;32:1707-1719.
40. Li H, Li Y, Liu D, Sun H, Liu J. miR-224 is critical for celastrol-induced inhibition of migration and invasion of hepatocellular carcinoma cells. Cell Physiol Biochem 2013;32: 448-458.
41. Wang D, Zhang H, Li M, Frid MG, Flockton AR, McKeon BA et al. MicroRNA-124 controls the proliferative, migratory, and inflammatory phenotype of pulmonary vascular fibroblasts. Circ Res 2014;114:67-78.
42. Zhao T, Li J, Chen AF. MicroRNA-34a induces endothelial progenitor cell senescence and impedes its angiogenesis via suppressing silent information regulator 1. Am J Physiol Endocrinol Metab 2010;299:E110-E116.
43. Witwer KW, Buzás EI, Bemis LT, Bora A, Lässer C, Lötvall J et al. Standardization of sample collection, isolation and analysis methods in extracellular vesicle research. J Extracell Vesicles 2013;2; doi:10.3402/jev.v2i0.20360. eCollection 2013.
44. Van Deun J, Mestdagh P, Sormunen R, Cocquyt V, Vermaelen K, Vandesompele J et al. The impact of disparate isolation methods for extracellular vesicles on downstream RNA profiling. J Extracell Vesicles 2014;3; doi:10.3402/jev.v3.24858. eCollection 2014.
45. Lötvall J, Hill AF, Hochberg F, Buzás EI, Di Vizio D, Gardiner C et al. Minimal experimental requirements for definition of extracellular vesicles and their functions: a position statement from the International Society for Extracellular Vesicles. J Extracell Vesicles 2014;3:26913.